Logo image
Heterogeneity of Anti-Phospholipid and Anti-Endothelial Cell Antibodies
Journal article   Open access   Peer reviewed

Heterogeneity of Anti-Phospholipid and Anti-Endothelial Cell Antibodies

Hua Shan, June Goldman, Gina Cunto, Joseph Manuppello, Irwin Chaiken, Douglas B Cines and Leslie E Silberstein
Journal of autoimmunity, v 11(6), pp 651-660
Dec 1998
PMID: 9878087
url
https://doi.org/10.1006/jaut.1998.0242View
Published, Version of Record (VoR)CC BY-NC-ND V4.0 Open

Abstract

anti-endothelial cell antibodies anti-phospholipid antibodies anti-phospholipid syndrome autoimmunity Ig variable gene usage
The role of the anti-phospholipid antibodies (APLA) and anti-endothelial cell antibodies (AECA) in the pathogenesis of anti-phospholipid syndrome (APS) is unclear. Differences in the reported involvement of APLA may be due, in part, to the polyclonal nature of these antibodies and the use of serum and serum fractions for analysis. To circumvent this issue, we generated monoclonal antibodies (MAB) from three patients with APS and two healthy controls. We then compared the antigen binding patterns and the heavy chain variable region (VH) DNA sequences of the MAB derived from patients with APS to those from healthy controls. The results of this study indicate that APLA and AECA comprise a highly heterogeneous population of antibodies with respect to the antigens they recognize, as well as VHgene usage. MAB derived from patients with APS do not differ from those derived from normal individuals based on either antigen recognition or VHgene usage. These results suggest the importance of additional predisposing factors in the pathogenesis of APS.

Metrics

9 Record Views
12 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Web of Science research areas
Immunology
Logo image